Article info
PDFOriginal research
Investigation of post-trial access views among study participants and stakeholders using photovoice and semistructured interviews
- Correspondence to Dr Nothando Ngwenya, Africa Health Research Institute, Durban 3935, South Africa; nothando.ngwenya{at}ahri.org
Citation
Investigation of post-trial access views among study participants and stakeholders using photovoice and semistructured interviews
Publication history
- Received October 31, 2020
- Accepted May 14, 2021
- First published June 25, 2021.
Online issue publication
September 28, 2022
Article Versions
- Previous version (28 September 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Other content recommended for you
- Implementing post-trial access plans for HIV prevention research
- Post-trial access to implantable neural devices: an exploratory international survey
- Post-trial access to study medication: a Brazilian e-survey with major stakeholders in clinical research
- Community engagement with HIV drug adherence in rural South Africa: a transdisciplinary approach
- Subjects’ views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) study
- Developing ethics guidance for HIV prevention research: the HIV Prevention Trials Network approach
- Introducing visual participatory methods to develop local knowledge on HIV in rural South Africa
- Maintaining cost-effective access to antiretroviral drug therapy through a collaborative approach to drug procurement, consensus treatment guidelines and regular audit: the experience of London HIV commissioners and providers
- Engagement in the HIV care cascade and barriers to antiretroviral therapy uptake among female sex workers in Port Elizabeth, South Africa: findings from a respondent-driven sampling study
- Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, Canada